Exercise program for children and young adults with cancer
Official title: LCI-PED-NOS-EXER-001: Just Move. A Randomized Controlled Trial Investigating Exercise in Pediatric Oncology Patients
Run by Wake Forest University Health Sciences · NCT05058508 · Data updated 2026-11-12
This study tests if a structured exercise program can help children and young adults with cancer feel better physically and emotionally while they are undergoing treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 2 Years to 25 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Charlotte, North Carolina) |
| Status | Recruiting |
| Started | March 11, 2024 |
| Main results expected | November 2027 |
| Study ends | November 2027 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT05058508 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children and young adults aged 2-25 who have recently been diagnosed with cancer and are about to start chemotherapy.
✕Probably not a fit
Patients with known cardiac dysfunction or certain types of tumors, such as primary CNS tumors or osteosarcoma, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the physical and emotional benefits of a structured exercise regimen for pediatric patients aged 2-25 who are newly diagnosed with blood or solid tumor cancers and undergoing treatment. Participants will be randomly assigned to either the exercise intervention group or a control group receiving standard care. The effectiveness of the exercise program will be measured using the 6-Minute Walk test and other assessments to evaluate physical functioning. The goal is to determine if exercise can help maintain or improve physical capabilities during cancer treatment.
Why it matters
Potential benefit: If successful, this study could enhance the physical and emotional well-being of young cancer patients during their treatment.
How similar studies have gone: Other studies have shown positive outcomes with exercise interventions in pediatric oncology, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Ages 2-25 at time of consent 2. Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy for at least 3 full cycles 3. Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language 4. As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study 5. Subject has newly diagnosed cancer per Investigator and is planning to undergo chemotherapy, immunotherapy, or other systemically delivered for treatment of malignancy. Subjects are allowed to be enrolled up to 21 days after initiating cancer treatment. 6. Receiving oncologic care at Levine Children's Cancer and Blood Disorders Clinic. 7. Subject is anticipated to receive at least 3 full cycles of chemotherapy or other systemic cancer treatment. 8. Not participating in another clinical trial that precludes participating in additional nondrug clinical trials. Exclusion Criteria: 1. Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program 2. Any other uncontrolled intercurrent illness/medical condition or psychiatric illness/social situations that would limit compliance with study requirements or would be considered unsafe for the child to participate as determined by the Investigator. 3. Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion 4. Primary CNS Tumor 5. Osteosarcoma
Where it's running
-
Levine Children's Hospital
Charlotte, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Jennifer Pope, MD — Wake Forest University Health Sciences
- Study coordinator: Meg Lattanze
- Email: Megan.Lattanze@advocatehealth.org
- Phone: (980) 442-4239
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
FaceSay: a computer program to help kids recognize facial expressions and improve social interactions
A computer-based FaceSay program is tested to see if it helps survivors of pediatric brain tumors who have social difficulties see facial expressions better and relate more comfortably with peers.
-
Access to Innovative Cancer Treatments for Children and Young People in Belgium
This observational study collects safety and effectiveness data on off‑label and compassionate cancer medicines used in kids and young adults up to age 25 in Belgium.
-
BCB-276 CAR T therapy for DIPG in children and young adults
This study tests BCB-276, a patient's own CAR T cells against DIPG, after standard radiation, to see if it is safe and can help extend survival.
-
CAYA cancer patients in LMICs: a forward-looking observation of care and outcomes
This study follows children, teens, and young adults with cancer in low- and middle-income countries to see how routine care affects treatment, access, and outcomes over time.
-
Virtual reality headsets to reduce anxiety and fear during intrathecal chemotherapy in children
This project will try virtual reality headsets with children aged 4–10 who are receiving intrathecal chemotherapy to see if they reduce anxiety, fear, and changes in vital signs.
-
Laser thermal therapy for young people with low-grade glioma
This research will test whether laser interstitial thermal therapy (LITT) can stop or slow recurrent or progressive low-grade gliomas in children, adolescents, and young adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.